Skip to main content

Table 1 Estimations used to model the burden of HCV in Turkey

From: A micro-elimination approach to addressing hepatitis C in Turkey

a. Base 2017 scenario
 201520162017 & 201820182019≥2020
Treated4200560010,200950088005600
Newly diagnosed550055005500550055005500
Fibrosis stage≥F0≥F3≥F1≥F1≥F1≥F1
Treated age15–7915–7915–7915–7915–7915–79
SVR49%97%99%99%99%99%
b. Increased treatment scenario
 201520162017 & 201820192020–2024≥2025
Treated4200560010,20011,00011,00011,000
Newly diagnosed550055005500550055005500
Fibrosis stage≥F0≥F3≥F1≥F0≥F0≥F0
Treated age15–7915–7915–7915–7915–7915–79
SVR49%97%99%99%99%99%
c. WHO targets scenario
 201520162017 & 201820192021–2024≥2025
Treated4200560010,20015,00016,00016,000
Newly diagnosed550055005500600018,00018,000
Fibrosis stage≥F0≥F3≥F1≥F1≥F0≥F0
Treated age15–7915–7915–7915–7915–7915–79
SVR49%97%99%99%99%99%
\